Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,006 DKK | +0.30% | +1.19% | +44.05% |
06-28 | India plans incentives for diabetes, obesity drug makers in 2026, government official says | RE |
06-28 | NOVO NORDISK : UBS gives a Neutral rating | ZD |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.05% | 638B | |
+55.32% | 819B | |
-6.75% | 351B | |
+13.56% | 329B | |
+10.68% | 298B | |
+16.57% | 242B | |
+2.04% | 225B | |
+13.31% | 217B | |
+8.48% | 168B | |
-2.81% | 158B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- Transcript : Novo Nordisk A/S, Q2 2023 Earnings Call, Aug 11, 2023